Company / Revenue per Share
NewAmsterdam Pharma Co N.V. Revenue per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.62
FY2025
5-year range
$0.39 / $5.41
FY2022-FY2025
Trend
-50.6%
vs FY2024
Sector context
#113 of 154
Health Care
What the data says
At $0.62, NewAmsterdam Pharma Co N.V.'s revenue per share ranks #113 of 154 in the Health Care sector. Improved from $0.39 to $0.62 over the past 2 years.
Based on SEC 10-K filings.
0.62 in FY2025 with a 3-year CAGR of -51.4%.
Improved from $0.39 to $0.62 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -51.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#113 of 154 in Health CareTop 73% of 154This company $0.62 Sector average $15.09
▼
-95.9% below sector average
Key checks
Key Insights
- In FY2025, revenue per share decreased 50.6% year-over-year.
- Ranks #113 out of 154 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.62 | -50.6% |
| FY2024 | $1.26 | +223.4% |
| FY2023 | $0.39 | -92.8% |
| FY2022 | $5.41 | - |
| FY2021 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026